DialysisRIDP001NCT07918066
Il Registro Italiano di Dialisi Pediatrica (RIDP) - Italian Registry of Pediatric Dialysis
An observational study of Dialysis and Kidney Transplantation, run by Istituto Giannina Gaslini at 12 sites in Italy.
Trial summary
The primary aim of the Registry, in addition to promoting collaboration and the sharing of protocols among participating centres, is to collect epidemiological, clinical, and biochemical data on patients, as well as technical data on dialysis treatments performed at Italian dialysis centres. Read more about this study
- Who is it for?
- Ages Up to 18 years
- Conditions the study is for
- Dialysis, Kidney Transplantation
- How many people
- 60 participants
- Where
- 12 sitesItaly
- Study dates
- 29 Jan 2024to 1 Jan 2032
- How long will I take part?
- 10 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation)
Who may be able to join
- Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation).
Who cannot join
- Duration of kidney replacement therapy of less than 30 days before any potential drop-out.
Trial locations and contacts
12 sites in 1 country. Contact the study team or a site near you to ask about taking part.
12 sites in 1 country
Italy12 sites, 12 recruiting
- Recruiting
Clinica Pediatrica, Nefrologia e Dialisi
Ancona
na na
- Recruiting
Ospedale Giovanni XXIII
Bari
na na
- Recruiting
Clinica Pediatrica, Nefrologia e Dialisi
Bologna
na na na
- Recruiting
Ospedale Meyer
Florence
na na na
- Recruiting
IRCCS Istituto Giannina Gaslini
Genova
Edoardo La Porta, 01056361, edoardolaporta@gaslini.org
- Recruiting
Nefrologia Pediatrica, Università
Messina
na na na
- Recruiting
Nefrologia, Dialisi e Trapianto, IRCCS Policlinico
Milan
na na
- Recruiting
Nefrologia e Dialisi, Ospedale Santobono
Naples
na na
- Recruiting
UO Nefrologia, Dialisi e Trapianto, Dipartimento di Pediatria
Padova
na na
- Recruiting
Nefrologia e Dialisi, Ospedale Di Cristina,
Palermo
na nan
- Recruiting
Ospedale Bambino Gesù,Nefrologia, Dialisi e Trapianto,
Roma
na na
- Recruiting
Ospedale Regina Margherita, Torino
Torino
na na
About this study
The primary aim of the Registry, in addition to promoting collaboration and the sharing of protocols among participating centres, is to collect epidemiological, clinical, and biochemical data on patients, as well as technical data on dialysis treatments performed at Italian dialysis centres.
- Conditions
- Dialysis, Kidney Transplantation
- Keywords
- dialysis, kidney transplantation, registry
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Age under 18 years at the initiation of the first course of chronic kidney replacement therapy | Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Collection of epidemiological, clinical, and biochemical data from patients, as well as technical data regarding dialysis treatments across various Italian dialysis centers.
Measured: through study completion, an average of 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2026
- Study start29 Jan 2024
- Primary completion1 Jan 2032 (estimated)
- Study completion1 Jan 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DialysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- Istituto Giannina Gaslini
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07918066
- Sponsor's protocol ID
- RIDP001 (11951)
- Acronym
- RIDP001
- Status last verified
- Oct 2026
- First submitted
- 13 Oct 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Il Registro Italiano di Dialisi Pediatrica (RIDP) - Italian Registry of Pediatric Dialysis
- ClinicalTrials.gov ID
- NCT07918066
- Acronym / sponsor ID
- RIDP001 / RIDP001 (11951)
- Conditions
- Dialysis, Kidney Transplantation
- Keywords
- dialysis, kidney transplantation, registry
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Istituto Giannina GasliniUniversity, hospital or other
- Study start
- 29 Jan 2024 (actual)
- Primary completion
- 1 Jan 2032 (estimated)
- Study completion
- 1 Jan 2032 (estimated)
- First posted
- 5 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary aim of the Registry, in addition to promoting collaboration and the sharing of protocols among participating centres, is to collect epidemiological, clinical, and biochemical data on patients, as well as technical data on dialysis treatments performed at Italian dialysis centres.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 10 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Age under 18 years at the initiation of the first course of chronic kidney replacement therapy | – | –Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation) |
Who may qualify
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation)
Key inclusion criteria (1 listed)
- Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation).
Key exclusion criteria (1 listed)
- Duration of kidney replacement therapy of less than 30 days before any potential drop-out.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Collection of epidemiological, clinical, and biochemical data from patients, as well as technical data regarding dialysis treatments across various Italian dialysis centers.
Time frame: through study completion, an average of 10 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Dialysis
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
Not yet recruiting
Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
Kidney Failure
RecruitingPhase 3
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Secondary Hyperparathyroidism, Chronic Kidney Disease
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Not yet recruitingPhase 1/2
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
End Stage Renal Disease, Fatigue
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
12 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dialysis and Kidney Transplantation, run by Istituto Giannina Gaslini at 12 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 12 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Edoardo La Porta (01056361, edoardolaporta@gaslini.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Collection of epidemiological, clinical, and biochemical data from patients, as well as technical data regarding dialysis treatments across various Italian dialysis centers. (time frame: through study completion, an average of 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.